Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, Nghiem P (2017) Merkel cell carcinoma. Nat Rev Dis Primers 26(3):17077

Article  Google Scholar 

Becker JC, Eigentler T, Frerich B, Gambichler T, Grabbe S, Höller U, Klumpp B, Loquai C, Krause-Bergmann A, Müller-Richter U, Pföhler C, Schneider-Burrus S, Stang A, Terheyden P, Ugurel S, Veith J, Mauch C (2019) S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin)—update 2018. J Dtsch Dermatol Ges 17(5):562–577

PubMed  Google Scholar 

Corti F, Lonardi S, Intini R, Salati M, Fenocchio E, Belli C, Borelli B, Brambilla M, Prete AA, Quarà V, Antista M, Fassan M, Morano F, Spallanzani A, Ambrosini M, Curigliano G, de Braud F, Zagonel V, Fucà G, Pietrantonio F (2021) The pan-immune-inflammation value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors. Eur J Cancer 150:155–167

CAS  Article  Google Scholar 

Donizy P, Wu CL, Kopczynski J, Pieniazek M, Biecek P, Ryś J, Hoang MP (2021) Prognostic role of tumoral PD-L1 and IDO1 expression, and intratumoral CD8+ and FoxP3+ lymphocyte infiltrates in 132 primary cutaneous merkel cell carcinomas. Int J Mol Sci 22(11):5489

CAS  Article  Google Scholar 

Fest J, Ruiter R, Ikram MA, Voortman T, van Eijck CHJ, Stricker BH (2018) Reference values for white blood-cell-based inflammatory markers in the Rotterdam study: a population-based prospective cohort study. Sci Rep 8(1):10566

Article  Google Scholar 

Fucà G, Guarini V, Antoniotti C et al (2020) The pan-immune-inflammation value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the valentino and TRIBE first-line trials. Br J Cancer 123:403–409

Article  Google Scholar 

Fucà G, Beninato T, Bini M et al (2021) The pan-immune-inflammation value in patients with metastatic melanoma receiving first-line therapy. Target Oncol 16(4):529–536

Article  Google Scholar 

Gaiser MR, Daily K, Hoffmann J, Brune M, Enk A, Brownell I (2015) Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers. Oncotarget 6(28):26472–26482

Article  Google Scholar 

Gambichler T, Schmitt K, Rüddel I, Dreißigacker M, Stockfleth E, Becker JC (2019) Decreased 5-hydroxymethylcytosine immunoreactivity in primary Merkel cell carcinoma is a strong predictor for disease-specific death. Br J Dermatol 181(2):389–390

CAS  Article  Google Scholar 

Garnier M, Zaragoza J, Bénéton N, Bens G, Meurisse V, Samimi M, Maillard H, Machet L (2018) High neutrophil-to-lymphocyte ratio before starting anti-programmed cell death 1 immunotherapy predicts poor outcome in patients with metastatic melanoma. J Am Acad Dermatol 79(1):165-167.e2

Article  Google Scholar 

Harms KL, Zhao L, Johnson B, Wang X, Carskadon S, Palanisamy N, Rhodes DR, Mannan R, Vo JN, Choi JE, Chan MP, Fullen DR, Patel RM, Siddiqui J, Ma VT, Hrycaj S, McLean SA, Hughes TM, Bichakjian CK, Tomlins SA, Harms PW (2021) Virus-positive Merkel cell carcinoma is an independent prognostic group with distinct predictive biomarkers. Clin Cancer Res 27(9):2494–2504

CAS  Article  Google Scholar 

Hernando-Calvo A, García-Alvarez A, Villacampa G et al (2021) Dynamics of clinical biomarkers as predictors of immunotherapy benefit in metastatic melanoma patients. Clin Transl Oncol 23(2):311–317

CAS  Article  Google Scholar 

Li C, Tian W, Zhao F et al (2018) Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors. Oncotarget 9(82):35293–35299

Article  Google Scholar 

Liu J, Charles PL, Zhou PB (2015) Inflammation fuels tumor progress and metastasis. Curr Pharm Des 21(21):3032–3040

CAS  Article  Google Scholar 

Ludwig JM, Haubold J, Bauer S et al (2021) Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion. Radiol Oncol 55(3):347–353

CAS  Article  Google Scholar 

Mirili C, Yılmaz A, Demirkan S, Bilici M, Basol TS (2019) Clinical significance of prognostic nutritional index (PNI) in malignant melanoma. Int J Clin Oncol 24(10):1301–1310

CAS  Article  Google Scholar 

Naseri S, Steiniche T, Georgsen JB, Thomsen R, Ladekarl M, Heje M, Damsgaard TE, Bønnelykke-Behrndtz ML (2020) Tumor ulceration, reduced infiltration of CD8-lymphocytes, high neutrophil-to-CD8-lymphocyte ratio and absence of MC virus are negative prognostic markers for patients with Merkel cell carcinoma. Cancers (basel) 12(4):888

CAS  Article  Google Scholar 

Nghiem P, Bhatia S, Lipson EJ, Sharfman WH, Kudchadkar RR, Brohl AS, Friedlander PA, Daud A, Kluger HM, Reddy SA, Boulmay BC, Riker A, Burgess MA, Hanks BA, Olencki T, Kendra K, Church C, Akaike T, Ramchurren N, Shinohara MM, Salim B, Taube JM, Jensen E, Kalabis M, Fling SP, Homet Moreno B, Sharon E, Cheever MA, Topalian SL (2021) Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma. J Immunother Cancer 9(4):002478

Article  Google Scholar 

Nishijima TF, Muss HB, Shachar SS et al (2015) Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev 41(10):971–978

Article  Google Scholar 

Polley MC, Dignam JJ (2021) Statistical considerations in the evaluation of continuous biomarkers. J Nucl Med 62(5):605–611

Article  Google Scholar 

Ricci C, Morandi L, Righi A, Gibertoni D, Maletta F, Ambrosi F, Agostinelli C, Uccella S, Asioli S, Sessa F, Pellilli M, Maragliano R, La Rosa S, Papotti MG, Asioli S (2019) PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters. Mod Pathol 32(9):1359–1372

CAS  Article  Google Scholar 

Riethdorf S, Hildebrandt L, Heinzerling L, Heitzer E, Fischer N, Bergmann S, Mauermann O, Waldispühl-Geigl J, Coith C, Schön G, Peine S, Schuler G, Speicher MR, Moll I, Pantel K (2019) Detection and characterization of circulating tumor cells in patients with Merkel cell carcinoma. Clin Chem 65(3):462–472

CAS  Article  Google Scholar 

Robinson AV, Keeble C, Lo MCI et al (2020) The neutrophil-lymphocyte ratio and locoregional melanoma: a multicentre cohort study. Cancer Immunol Immunother 69(4):559–568

CAS  Article  Google Scholar 

Şahin AB, Cubukcu E, Ocak B, Deligonul A, Oyucu Orhan S, Tolunay S, Gokgoz MS, Cetintas S, Yarbas G, Senol K, Goktug MR, Yanasma ZB, Hasanzade U, Evrensel T (2021) Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy. Sci Rep 11(1):14662

Article  Google Scholar 

Schisterman EF, Faraggi D, Reiser B, Hu J (2008) Youden Index and the optimal threshold for markers with mass at zero. Stat Med 27(2):297–315

Article  Google Scholar 

Susok L, Said S, Reinert D, Mansour R, Scheel CH, Becker JC, Gambichler T. The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy. J Cancer Res Clin Oncol (in press)

Templeton AJ, Ace O, McNamara MG et al (2014) Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 23(7):1204–1212

CAS  Article  Google Scholar 

Zaragoza J, Caille A, Beneton N, Bens G et al (2016a) High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma. Br J Dermatol 174(1):146–151

CAS  Article  Google Scholar 

Zaragoza J, Kervarrec T, Touzé A, Avenel-Audran M, Beneton N, Esteve E, Wierzbicka Hainaut E, Aubin F, Machet L, Samimi M (2016b) A high neutrophil-to-lymphocyte ratio as a potential marker of mortality in patients with Merkel cell carcinoma: a retrospective study. J Am Acad Dermatol 75(4):712-721.e1

Article  Google Scholar 

Zeng R, Liu F, Fang C, Yang J, Luo L, Yue P, Gao B, Dong Y, Xiang Y (2021) PIV and PILE score at baseline predict clinical outcome of anti-PD-1/PD-L1 inhibitor combined with chemotherapy in extensive-stage small cell lung cancer patients. Front Immunol 12:724443

CAS  Article  Google Scholar 

Zhong JH, Huang DH, Chen ZY (2017) Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis. Oncotarget 8(43):75381–75388

Article  Google Scholar